Lonza Boosts Advanced Synthesis Capabilities for Bioconjugates
Lonza has expanded its advanced synthesis portfolio to provide end‑to‑end support for antibody‑drug conjugates (ADCs) and other bioconjugates. The company fully integrated the Synaffix‑derived ADC platform—including GlycoConnect® conjugation, HydraSpace® spacers and toxSYN® linker payloads—into its services. A new dual‑payload ADC capability enables two complementary cytotoxics to be attached to a single antibody with controllable ratios. The Oss, Netherlands site now offers small‑scale prototyping, pilot‑scale toxicology material, and expanded work on antibody‑oligonucleotide conjugates, lipid nanoparticles and protein‑protein conjugates.
HHS Burrows Into Identifying Risks to Health Sector From Third-Party Vendors
HHS is intensifying its focus on third‑party vendor security after the 2024 Change Healthcare ransomware attack, which exploited a remote‑access portal lacking multifactor authentication and exposed the data of about 190 million individuals. The breach threatened the liquidity of the entire...
6 Ways Hospitals Can Structure CMS TEAM Collaboration Agreements with Specialists
The CMS Transforming Episode Accountability Model (TEAM) now holds hospitals financially accountable for costly surgical episodes, prompting a shift toward true specialist collaboration. Hospitals must craft Collaboration Agreements that align incentives, share data, and avoid punitive scoring to keep surgeons...
GE HealthCare Nabs 3 Notable MRI FDA Clearances
GE HealthCare announced FDA clearance for three next‑generation MRI products: the 1.5‑T Signa Sprint with Freelium, the 3‑T Signa Bolt, and the AI‑driven workflow platform Signa One. The Sprint uses a helium‑free magnet that consumes less than 1 % of traditional coolant, while the...
MIT Researchers Develop Miniaturized Breast Ultrasound Wearable
MIT researchers have created a miniature ultrasound system roughly the size of a smartphone and costing about $300, capable of capturing real‑time three‑dimensional breast images. The device uses a square‑array probe with CODA geometry, reducing transducer elements from 1,024 to...
Amazfit Debuts T-Rex Ultra 2 Watch with Biotracking, 30-Day Battery
Amazfit, Zepp Health’s flagship wearable brand, launched the T‑Rex Ultra 2, a rugged GPS smartwatch aimed at extreme‑environment users. The device combines comprehensive biotracking—heart rate, SpO₂, sleep, breathing, and stress metrics—with 30‑day battery life, 100‑metre water resistance, and a Low Temperature...
How Health Systems Reduce the Strain of Documentation Burden
Health systems are turning to cloud‑based generative AI to slash documentation overload. City of Hope deployed HopeLLM, an agentic large‑language‑model platform that creates concise medical‑history summaries in minutes, freeing clinicians from nightly “pajama time.” Providence built Provaria on Azure, using...
Britain’s Labour Government Feels the Heat over Palantir Contracts
Britain’s Labour government is under growing pressure over its contracts with U.S. data‑analytics firm Palantir, which include a £330 million NHS platform and a £240 million defence deal awarded without competition. Critics cite the company’s founder Peter Thiel, its work with ICE, and...
Hims & Hers Acquires Australian Digital Health Eucalyptus for Up to $1.15B
Hims & Hers Health announced a definitive agreement to acquire Australian digital‑health firm Eucalyptus for up to $1.15 billion, with $240 million paid in cash and the balance structured as deferred and earn‑out payments. Eucalyptus, founded in 2019, serves more than 775,000...
Obesity Biotech Verdiva Plans Big Year of Data, Explores Deals
Verdiva Bio, an obesity‑focused biotech, is gearing up for a data‑heavy 2026, with Phase 2 results for its lead long‑acting peptide slated for the third quarter. The company is also courting strategic partnerships, eyeing potential deals with major pharma players after...
Caregivers Find Much-Needed Relief with This Unique Eldercare Solution
CareYaya, a student‑matching platform, connects college students with seniors and disabled adults to provide non‑medical in‑home assistance. By paying students directly at about $20 an hour, the service reduces care costs roughly 50 % compared with traditional agencies. The app’s algorithm...
Redefining Obesity Treatment Beyond GLP-1 Limits
BioSpace’s Denatured podcast featured Verdiva Bio’s R&D head Jane Hughes and MitoRx CEO Jon Rees discussing next‑generation obesity therapies that move beyond the limitations of GLP‑1 agonists. They highlighted how GLP‑1 treatments can cause muscle loss and suffer from poor...
MedStar Health, Withings Bring Connected Devices to Concierge Medicine Program
MedStar Health is scaling its Signature concierge primary‑care program by partnering with Withings Health Solutions to supply patients with cellular blood‑pressure cuffs and scales. The collaboration leverages MedStar’s existing telehealth and remote‑patient‑monitoring infrastructure to collect real‑world physiologic data outside the...
4 Out of 5 Rural Texans Face a “Life-Threatening” Chronic Disease Crisis, PCCI Data Shows
An analysis by the Parkland Center for Clinical Innovation using its Community Vulnerability Compass finds that four out of five rural Texans live in areas highly vulnerable to life‑threatening chronic diseases. Over 670,000 residents face elevated risk for coronary heart...
Biogen Stops Part of an MS Trial; Merck Reports More Enflonsia Data
Biogen announced it is halting the combination‑therapy arm of its multiple sclerosis (MS) trial after interim data showed insufficient efficacy and safety concerns. The decision pauses enrollment in the experimental regimen while the company continues evaluating its monotherapy components. Meanwhile,...
Medtronic’s RDN System Receives New Reimbursement Approval
Medtronic’s Symplicity Spyral renal denervation system has secured reimbursement approval from Japan’s Ministry of Health, Labour and Welfare, expanding coverage for resistant hypertension. The therapy, which uses radio‑frequency energy to ablate renal nerves via a single catheter, was previously approved...
New Mexico Hospital Deploys AI Platform Enterprisewide
San Juan Regional Medical Center in Farmington, New Mexico, has rolled out Wellsheet’s AI documentation platform across its entire enterprise. The solution, already active in more than 100 U.S. hospitals, promises physicians 90‑120 minutes of daily documentation savings and a...
FDA Issues Early Alert on Trividia Glucometer Issue Linked to 114 Injuries
The FDA issued an early alert after linking Trividia Health’s True Metrix glucometers to 114 injuries and one death. The alert cites an E‑5 error code that appears when blood glucose exceeds 600 mg/dL or when a test‑strip fault occurs, potentially...
University of Mississippi Medical Center Closes All Clinics in Wake of Cyberattack
The University of Mississippi Medical Center (UMMC) suffered a severe cybersecurity breach on Thursday, forcing multiple IT systems offline, including its Epic electronic medical records platform. The outage crippled access to patient data, prompting the Jackson‑based health system to shut...
Sustaining Clinician Independence: Why Simplicity, Not Consolidation, Is Key to Solving the Mental Health Crisis
The article argues that America’s mental‑health crisis cannot be solved by consolidating providers; instead, preserving clinician independence is essential. While demand outpaces supply, most mental‑health clinicians still operate solo or in small groups, delivering timely, high‑quality care. Consolidation introduces administrative...
Valneva’s Lyme Disease Vaccine Offers Beacon of Hope Amid 2025 Sales Dip
Valneva reported a 3.3% decline in product sales to €157.9 million in 2025, driven primarily by regulatory suspensions of its chikungunya vaccine Ixchiq in the US and UK. Despite the sales dip, total revenue rose to €174.7 million, buoyed by a licensing...
Pembrolizumab-Induced Adrenal Insufficiency: Recognizing and Managing a Diagnostic Challenge in Adjuvant NSCLC Therapy
Pembrolizumab used as adjuvant therapy for NSCLC can cause central adrenal insufficiency, presenting with nonspecific fatigue, nausea, and hyponatremia. In a 67‑year‑old patient, a markedly low morning cortisol and suppressed ACTH confirmed the diagnosis within ten weeks of treatment. Prompt...
Hospitals and Area Agencies on Aging Work Together to Advance Social Connection
One‑fifth of Americans aged 50+ live alone, raising isolation‑related health risks. Hospitals and Area Agencies on Aging (AAAs) are increasingly partnering to screen for loneliness and deliver social‑connection programs, with 98% of AAAs and nearly 80% of hospitals now active...
Investors Unfazed by Uncertainties Around Tariffs in Med Tech
Investors remain steady in the med‑tech sector despite lingering tariff uncertainties, signaling confidence in long‑term growth. At the same time, research updates highlight the SCAN circuit as a core driver of Parkinson’s disease, TL1A overexpression in hidradenitis suppurativa, and an...
Cetirizine and Levocetirizine Withdrawal Pruritus: What Pharmacists Need to Know About the FDA’s New Safety Warning
The FDA will update labeling for cetirizine and levocetirizine to warn of a rare but serious withdrawal‑related pruritus that can emerge days after stopping long‑term use. More than 200 adverse‑event reports, primarily linked to cetirizine, describe severe itching requiring medical...
Health Systems Must Connect with Patients in More Meaningful Ways
Health systems are accelerating digital transformation post‑COVID, with HIMSS research showing that hospitals possessing advanced digital maturity are 3.25 times more likely to earn higher safety grades and experience lower infection and adverse event rates. The pandemic also shifted patients from...
2024-2025 COVID-19 Vaccines Provided Moderate Protection Against JN.1 Variants
A recent JAMA Network Open case‑control study of 8,493 hospitalized adults shows that 2024‑2025 COVID‑19 vaccines provided moderate protection against the JN.1 lineage, with overall effectiveness of 40% against hospitalization and up to 52% after 90‑179 days. Updated Moderna and...
Insulin Affordability: Policies and Pharmacist Roles in Diabetes Management
Insulin’s list price has surged more than 300% over the past two decades, driven by a rebate‑heavy gross‑to‑net bubble and limited biosimilar competition. Pharmacy‑benefit managers (PBMs) dominate 79% of the market, using high‑list‑price rebates to secure formulary placement, which inflates...
Imaging Data Liquidity: The Foundation of Multimodal Medical Intelligence
Healthcare’s imaging assets—radiology and digital pathology—are evolving from isolated diagnostic tools into a strategic, enterprise‑wide intelligence layer. Current PACS and VNA infrastructures were built for episodic access, limiting data recombination, longitudinal analysis, and outcome linkage. The article argues that achieving...
Navigating GLP-1 Costs With Eric Levin: Insurance, Cash Pay, and the Oral Wegovy Shift
Eric Levin, CEO of Scripta, explains that the newly launched oral Wegovy pill is typically cheaper on a cash‑pay basis—by a few hundred dollars per month—than injectable GLP‑1s, but insurance reimbursements are currently similar for both forms. Coverage depends heavily...
Why Alivia Care Is Getting Invested in ACO Models
Alivia Care is committing to high‑needs Accountable Care Organization models, finishing the 2026 ACO REACH program and planning to join the new Long‑term Enhanced ACO Design (LEAD) model starting in 2027. ACO REACH has generated more than $70 million in Medicare...
DHL Group Invests €2bn in Healthcare Logistics Push
DHL Group announced a €2 billion strategic investment to expand its Life Sciences & Healthcare air‑freight cold‑chain network. The rollout adds more than 30 GDP‑compliant aviation hubs and a dedicated Boeing 777F route between Brussels and Cincinnati, linking Europe’s life‑science cluster...
Veradigm Cut 15% of Its Workforce in 2025
Veradigm announced a 15% workforce reduction in 2025, closed three offices and plans two more closures, and will discontinue six low‑revenue products as part of a broader turnaround. The health‑IT firm is also focused on updating its financial filings after...
STAT+: Pharmalittle: We’re Reading About the FDA Pushing OTC Meds, Its New Trial Standards, and Much More
The FDA, under Commissioner Marty Makary, is pushing to expand over‑the‑counter (OTC) availability for safe prescription drugs such as nausea treatments and vaginal estrogen. Simultaneously, the agency proposes dropping the long‑standing requirement for two pivotal clinical trials, moving to a...
How Medplum Secured Their Healthcare Platform with Docker Hardened Images (DHI)
Medplum, an open‑source headless EHR serving over 20 million patients, migrated its production containers to Docker Hardened Images (DHI) with just 54 lines of code changes across five files. The switch replaced custom hardening scripts with Docker’s secure‑by‑default base images, eliminating...
4 Ways a Technology-Enabled Medical Center Can Improve Your Weight Loss Journey
Obesity affects over 42% of U.S. adults, prompting a surge in weight‑loss solutions. Technology‑enabled medical centers combine clinical expertise with digital tools to deliver data‑driven, personalized programs. By continuously monitoring biomarkers, body composition and activity, they adapt nutrition and exercise...
Treg Pioneer Bluestone Joins Vie Ventures as It Builds Autoimmune Portfolio
Vie Ventures has hired immunology veteran Jeff Bluestone to strengthen its autoimmune‑focused venture portfolio. Bluestone, founder of the Immune Tolerance Network and former CEO of the Parker Institute for Cancer Immunotherapy, previously co‑founded Sonoma Biotherapeutics and created Tzield teplizumab, the...
LPM-5140276 Shows Enhanced Antitumor Efficacy in Combination with RMC-4550
Researchers reported that the novel KRAS G12D inhibitor LPM-5140276 markedly improves antitumor activity when paired with the SHP2 inhibitor RMC-4550. The combination demonstrated synergistic tumor regression in preclinical models of pancreatic and colorectal cancers harboring KRAS G12D mutations. Data suggest enhanced pathway...
Blackbird-Backed Telehealth Startup Eucalyptus Sells for $1.6 Billion to US Listed Rival
Australian telehealth startup Eucalyptus is being acquired by NYSE‑listed Hims & Hers for $1.15 bn, valuing the company at A$1.6 bn. The deal includes an upfront $240 m payment and deferred cash or stock plus earn‑out provisions through 2029. Eucalyptus reports an ARR north...
ViiV Healthcare Reports P-III (LATITUDE) Trial of Cabenuva in Adherence-Challenged HIV Patients
ViiV Healthcare presented results from the Phase III LATITUDE trial evaluating Cabenuva, a long‑acting injectable of cabotegravir and rilpivirine, in 453 adults with adherence challenges. Among 306 virally suppressed participants, the quarterly injection reduced cumulative regimen failure to 22.8% versus...
Radiopharmaceutical Therapy Use Has Increased 2,000% Among Medicare Population
Radiopharmaceutical therapy (RPT) utilization among Medicare beneficiaries surged 2,000% between 2013 and 2023, climbing from 529 to 12,395 IV administrations. The study identified a 37% compound annual growth rate, with diagnostic and interventional radiology delivering 45.2% of services and nuclear...
High Risk Research: HHS Should Publicly Share More Information on How Risk Is Assessed and Mitigated
The Government Accountability Office (GAO) reports that the Department of Health and Human Services (HHS) conducts risk assessments for gain‑of‑function research but does not consistently share those findings with the public. While the research has expanded understanding of pathogen transmission,...
Roland DGA Launches Elevate Denture Solution for Digital Workflows
Roland DGA has introduced the Elevate Denture Solution, a digital denture kit that bundles Ivoclar Ivotion discs, hyperDENT CAM strategies, adapters and PMMA tooling for use with DGSHAPE DWX‑53 series mills. Developed with Ivoclar and FOLLOW‑ME! Technology, the solution offers...
Private Health Insurance: Provider Participation and Payments for Selected Services Before and After the No Surprises Act
The Government Accountability Office examined how the No Surprises Act affected provider participation and payment levels for emergency medicine, radiology, anesthesiology and air‑ambulance services from 2019 through 2023. After the act’s protections took effect on January 1 2022, the share of in‑network...
CRISPR Therapeutics Gains After Earnings as Pipeline Hope Grows
CRISPR Therapeutics shares rose over 12% after reporting Q4 2025 earnings that showed a larger‑than‑expected loss and minimal recognized revenue. The company’s flagship therapy CASGEVY generated $54 million in sales, but under its revenue‑sharing deal with Vertex only $0.86 million was recorded. CRISPR...
STAT+: What to Expect From Gossamer Bio’s Late-Stage Lung Disease Study
Gossamer Bio is set to announce results from its Phase 3 trial in pulmonary arterial hypertension (PAH) before the end of February. The readout follows a Phase 2 study that delivered modest, sub‑par efficacy, which the company attributes to an...
DHL Expands Airfreight Cold Chain Network
DHL Group is expanding its dedicated air‑freight cold‑chain network, adding more than 30 GDP‑compliant aviation hubs and a new Brussels‑Cincinnati corridor. The rollout is part of a €2 bn investment in DHL Health Logistics and includes a dedicated Boeing 777 freighter painted...
Anthropic: It’s “Critical” To Bring Company Products to EHR
Anthropic is pushing its Claude AI model into electronic health record (EHR) systems, arguing that integration is essential for real‑time clinical value. The company highlighted a roster of 25 healthcare partners, including Abridge, Novo Nordisk, Genmab and Banner Health, to showcase both...
Prevention Is Turning a Corner as Public Demand Surges – but NHS Digital Infrastructure Is Still Lagging Behind
Public demand for preventative health in the UK is surging, with NHS App registrations now at 33.6 million – roughly twice the nation’s Netflix subscriber base. A PA Consulting survey shows eight‑in‑ten NHS leaders believe digital tools can cut health inequalities,...
Nevada Debuts Public Option Amid Tumultuous Federal Changes to Health Care
Nevada launched its Battle Born public option health plans last fall, aiming to lower premiums and expand coverage. Early enrollment reached just over 10,000 members, far short of the 35,000 target set by state officials. The program must cut premiums...